Old Web
English
Sign In
Acemap
>
Paper
>
Alemtuzumab improves disability and quality of life outcomes over 8 years in patients with RRMS
Alemtuzumab improves disability and quality of life outcomes over 8 years in patients with RRMS
2019
Heinz Wiendl
Rany A Aburashed
Raed Alroughani
Aaron Boster
Andrew T. Chan
Dominique Dive
S. Eichau
Daniel Kantor
Ho Jin Kim
Christopher LaGanke
Jan Lycke
R Macdonell
C. Pozzilli
Thomas F. Scott
P. Vermersch
Z. Choudhry
Nadia Daizadeh
Darren P. Baker
Samuel F. Hunter
Keywords:
Physical therapy
Alemtuzumab
Medicine
Quality of life
clinical neurology
Pediatrics
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]